Add Yahoo as a preferred source to see more of our stories on Google. Wegovy and other injectable weight-loss medications have soared in popularity in the past two years. Supply issues and spotty ...

In 2017, the FDA approved semaglutide, an injectable GLP-1 agonist medication sold under the name Ozempic, for the management of type 2 diabetes. Later, the pharmaceutical company that makes Ozempic ...

Whether it’s due to an ingredient allergy or other reasons, compounding pharmacies can help tailor a custom-made medication to meet your needs. And when drug shortages happen, they can play an ...

Mon, February 10, 2025 at 4:52 AM UTC Some call these medications “generic Ozempic” (they’re not); others, “fake Ozempic” (nope, except when the ads are for illegal or nonexistent drugs). And last ...

Discover how compounding pharmacies are transforming healthcare by creating tailor-made medications for patients with unique needs, offering critical alternatives when standard drugs fall short, and ...

Weight-loss treatments like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have been life changing for many individuals seeking to manage their weight. However, shortages and high ...

Compounded medications are custom drugs, which the FDA does not regulate like regular prescription drugs. You may need ...

The FDA has banned compounded versions of GLP-1 drugs like semaglutide or tirzepatide due to safety concerns, and supplies of these copycats are expected to drop. Compounded drugs can carry serious ...

The state Senate passed a bill Friday regulating copycat versions of popular weight loss drugs like Ozempic and Wegovy.

You’ve probably seen compounding making headlines recently, and not for the right reasons. From so-called “personalized” GLP-1s flooding the market to telehealth startups touting hormone “rebalancing” ...

A new "best practices" guide released by the Alliance for Pharmacy Compounding (APC) aims to educate compounding pharmacists and reassure prescribers about the ethical, legal, and practical ...